Completed Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck NCT02113878 Conditions Cancer of Nasopharynx, Carcinoma, Carcinoma of Larynx, +23 more Locations Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
